<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137920">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01906281</url>
  </required_header>
  <id_info>
    <org_study_id>Joan01</org_study_id>
    <nct_id>NCT01906281</nct_id>
  </id_info>
  <brief_title>Influence of Adipocytokines in Osteoarthritis</brief_title>
  <official_title>Adipocytokines Influence on Clinical and Ultrasonographic Inflammatory Activity in Patients With Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Parc Taulí, Sabadell</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Parc Taulí, Sabadell</source>
  <oversight_info>
    <authority>Spain: Comité Ético de Investigación Clínica</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adipocytokines play an important role in joint inflammation in patients with knee
      osteoarthritis as measured by ultrasound and high sensitivity protein-C reactive.
      Adipocytokines could be the link between osteoarthritis and cardiovascular risk factors more
      prevalent in these patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>adipocytokine level</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will determine the adipocytokine level at the end of inclusion period between 12-18 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ultrasound inflammatory exploration of the knee</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>we evaluate the presence of synovial fluid with ultrasound evaluation in the visit of the patient. Ultrasound evaluation will be performed by two Rheumatologists.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasound of carotid artery</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will evaluate patients with ultrasound exploration in order to describe the presence of atheromatous disease in the visit of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular risk factors</measure>
    <time_frame>18months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We evaluate the prevalence of cardiovascular risk factors in the symptomatic knee osteoarthritis patients, and the relationship with adipocytokines. We will evaluate blood analyse levels of cholesterol, glycemia.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Endocrine System Diseases</condition>
  <condition>Cardiovascular Risk Factors</condition>
  <arm_group>
    <arm_group_label>Inflammatory knee osteoarthritis</arm_group_label>
    <description>One group of patients with inflammatory condition in physical evaluation. We will make a blood analyse and arthrocentesis when synovial fluid were found in ultrasound examination. Ultrasound of affected knee and carotid artery will be performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-inflammatory knee osteoarthritis</arm_group_label>
    <description>Patients with no inflammatory condition in physical examination. We will make a blood analyse and arthrocentesis when synovial fluid were found in ultrasound examination. Ultrasound of affected knee and carotid artery will be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood analyse, arthrocentesis, ultrasound examination</intervention_name>
    <arm_group_label>Inflammatory knee osteoarthritis</arm_group_label>
    <arm_group_label>Non-inflammatory knee osteoarthritis</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      First we analyze the blood and articular fluid adipocytokines. If we can define a subset of
      patients characterized by a pattern of adipocytokines, genetic analysis will be performed
      later.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients over 50 years who were referred for rheumatology for symptomatic knee
        osteoarthritis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 50 years old with symptomatic knee osteoarthritis.

        Exclusion Criteria:

          -  Patients with secondary osteoarthritis of the knee

          -  Any other rheumatologic condition.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jordi Gratacos, MD Ph</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Parc Tauli</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joan Calvet, Dr</last_name>
    <phone>0034 937231010</phone>
    <phone_ext>24065</phone_ext>
    <email>joan.calvet.fontova@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cristobal Orellana, Dr</last_name>
    <phone>0034 937231010</phone>
    <phone_ext>24059</phone_ext>
    <email>cristobalorellana1@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Parc Tauli Sabadell</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Calvet, Dr</last_name>
      <phone>0034937231010</phone>
      <phone_ext>24065</phone_ext>
      <email>joan.calvet.fontova@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Joan Calvet, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristobal Orellana, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Garcia-Manrique, Dra</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Calvet, Dr</last_name>
      <phone>0034937231010</phone>
      <phone_ext>24065</phone_ext>
      <email>joan.calvet.fontova@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Cristobal Orellana, Dr</last_name>
      <phone>0034937231010</phone>
      <phone_ext>24065</phone_ext>
      <email>corellana@tauli.cat</email>
    </contact_backup>
    <investigator>
      <last_name>Joan Calvet, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristobal Orellana, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Garcia-Manrique, Dra</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 7, 2013</lastchanged_date>
  <firstreceived_date>July 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Parc Taulí, Sabadell</investigator_affiliation>
    <investigator_full_name>Joan Calvet Fontova</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>adipocytokines</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>cardiovascular risk</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endocrine System Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
